CRT 2024

Biological Basis and Proposed Mechanism of Action of CSL112 (apolipoprotein A-I [human]) for Prevention of Major Adverse Cardiovascular Events in Patients with Myocardial Infarction

Speaker(s)

• 

  C. Michael Gibson, MD

  Professor of Medicine
  Beth Israel Deaconess Medical Center
  Boston, Massachusetts, United States

  No relationships to disclose